R & D of medicine and vaccine for Ebola hemorrhagic fever
10.7644/j.issn.1674-9960.2014.08.001
- VernacularTitle:埃博拉出血热药物和疫苗研究开发态势分析
- Author:
Tianxi DIAO
;
Shoujun XU
;
Xiaoyu ZHAO
;
Wei ZHOU
;
Peng LI
;
Shu LIU
;
Wei WANG
- Publication Type:Journal Article
- Keywords:
Ebola virus;
Ebola hemorrhagic Fever;
medicine;
vaccine
- From:
Military Medical Sciences
2014;(8):569-575
- CountryChina
- Language:Chinese
-
Abstract:
The outbreak of Ebola hemorrhagic fever in West Africa in February 2014 is the worst one in the history of the disease.Medicines and vaccines for Ebola have attracted special attention .This study utilizes Cortellis database of Thom-son Reuters and knowledge about Ebola virus to analyze current R&D of medicines and vaccines for Ebola in order to offer references for research and development .Study findings shows that there are mainly 5 important categories:vaccines, neu-tralizing antibodies , small-molecule anti-Ebola drugs , RNAi drugs and nucleotide drugs .In each category , there are prom-ising products under development that are worthy of attention .
